FIELD: organic chemistry, biology, medicine.
SUBSTANCE: invention elates to derivatives of indole of the general formula (I):
wherein R1 represents hydrogen atom, halogen atom, methoxy-group; R2 represents hydrogen atom, halogen atom, methyl, ethyl, methoxy-group; R3 represents carboxy-group, tetrazolyl or -CONHSO2R4 wherein R4 represents methyl, ethyl, phenyl, 2,5-dimethylisoxazolyl, trifluoromethyl; T represents -CH2- or -SO2-; ring A represents 3-chlorophenyl, 4-chlorophenyl, 3-trifluoromethylphenyl, 3,4-dichlorophenyl, 3,4-difluorophenyl, 3-fluoro-4-chlorophenyl, 3-chloro-4-fluorophenyl, 2,3-dichloropyrid-5-yl; or their pharmaceutically acceptable salts or esters and also pharmaceutical compositions containing thereof. These compounds and compositions can be used in treatment of disease mediated by monocytic hemoattractant protein-1 or RANTES (regulated in activation, expressed and secreted by normal t cells), such as inflammatory disease.
EFFECT: valuable biological and medicinal properties of compounds.
10 cl, 1 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 4-MERCAPTOPYRROLIDINE AS INHIBITORS OF FARNESYLTRANSFERASE | 1996 |
|
RU2191773C2 |
SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND USING THEM | 2010 |
|
RU2553263C2 |
INHIBITORS OF HIV INTEGRASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2002 |
|
RU2284315C2 |
DERIVATIVES OF SUBSTITUTED PYRROLOPYRIDINONE USEFUL AS PHOSPHODIESTERASE INHIBITORS | 2001 |
|
RU2267490C2 |
DERIVATIVES OF ADAMANTANE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT | 2000 |
|
RU2254333C2 |
DERIVATIVES OF AROYLPIPERAZINE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT | 1998 |
|
RU2258702C2 |
4-PHENYL-SUBSTITUTED TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT BASED ON THEREOF | 2001 |
|
RU2301808C2 |
PHENYLPYRIDAZINE COMPOUNDS AND MEDICINAL AGENTS COMPRISING THEREOF | 2001 |
|
RU2269519C2 |
DERIVATIVES OF BENZIMIDAZOLE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1998 |
|
RU2243968C2 |
HETEROCYCLIC COMPOUNDS FOR TYROSINE KINASE 2 ACTIVITY MEDIATION | 2020 |
|
RU2826012C2 |
Authors
Dates
2004-08-27—Published
2000-01-31—Filed